Regular imaging surveillance, within 30-days of repair and annually thereafter, may help identify adverse events, such as endoleaks or failure of aneurysm sac regression. The panel recommended that a six-month follow-up be completed if any concerns are raised in the initial imaging.
FDA panel members also recommended the creation of a real-world surveillance system to collect data through 10 years post-procedure.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
